Science Explorer Back to mapMap
Discussion
Institution · Alphabio

Most cited papers from Alphabio

Alphabio

What are the most cited papers from Alphabio?

The most cited paper from Alphabio is "Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes *" (Peter Simmonds et al., 2005), with 1,514 citations. Next come "Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial" (761) and "CpG Methylation Controls Reactivation of HIV from Latency" (335).

Showing 50 of 60 papers. Every paper with more than 62 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes * Peter Simmonds et al. · Hepatology Open access 7 Sep 2005 1,514
2 Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial Jacques Durant, Philippe Albert Clevenbergh, Philippe Halfon et al. · The Lancet Jun 1999 761
3 CpG Methylation Controls Reactivation of HIV from Latency Jana Blažková, Kateřina Trejbalová, Françoise Gondois‐Rey et al. · PLoS Pathogens Open access 20 Aug 2009 335
4 Meta-analyses of FibroTest diagnostic value in chronic liver disease Thierry Poynard, Rachel Morra, Philippe Halfon et al. · BMC Gastroenterology Open access 15 Oct 2007 320
5 Hepatitis C virus resistance to protease inhibitors Philippe Halfon, Stephen Locarnini · Journal of Hepatology Open access 2 Feb 2011 306
6 AF Ablation Guided by Spatiotemporal Electrogram Dispersion Without Pulmonary Vein Isolation Julien Seitz, Clément Bars, Guillaume Théodore et al. · Journal of the American College of Cardiology Open access 2017 252
7 Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages Thierry Poynard, Philippe Halfon, Laurent Castéra et al. · Clinical Chemistry 19 Jul 2007 239
8 HCV direct‐acting antiviral agents: the best interferon‐free combinations Raymond F. Schinazi, Philippe Halfon, Patrick Marcellin et al. · Liver International Open access 23 Dec 2013 230
9 Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study Jacques Durant, Philippe Albert Clevenbergh, R. Garraffo et al. · AIDS Jul 2000 222
10 Multicentre prospective study on dengue classification in four South‐east Asian and three Latin American countries Neal D. E. Alexander, Ángel Balmaseda, Ivo Castelo Branco Coêlho et al. · Tropical Medicine & International Health Open access 30 May 2011 218
11 Association of Autofluorescence-Based Detection of the Parathyroid Glands During Total Thyroidectomy With Postoperative Hypocalcemia Risk Fares Benmiloud, Gaelle Godiris-Petit, Régis Gras et al. · JAMA Surgery Open access 6 Nov 2019 214
12 SAFE biopsy Giada Sebastiani, Philippe Halfon, Laurent Castéra et al. · Hepatology Open access 2 Feb 2009 182
13 Genome-Wide Association Study Identifies Variants Associated With Progression of Liver Fibrosis From HCV Infection Étienne Patin et al. · Gastroenterology Open access 27 Jul 2012 178
14 Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae Anaïs Potron, Emilie Rondinaud, Laurent Poirel et al. · International Journal of Antimicrobial Agents Open access 8 Jan 2013 173
15 Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process Xavier Adhoute, Guillaume Pénaranda, Sébastien Naudé et al. · Journal of Hepatology 21 Nov 2014 172
16 d -Ala- d -Ser VanN-Type Transferable Vancomycin Resistance in Enterococcus faecium François Lebreton, Florence Depardieu, Nancy Bourdon et al. · Antimicrobial Agents and Chemotherapy Open access 2 Aug 2011 170
17 Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients Caroline Solas, Alain Lafeuillade, Philippe Halfon et al. · Antimicrobial Agents and Chemotherapy Open access 24 Dec 2002 162
18 Independent Prospective Multicenter Validation of Biochemical Markers (Fibrotest-Actitest) for the Prediction of Liver Fibrosis and Activity in Patients with Chronic Hepatitis C: The Fibropaca Study Philippe Halfon, Marc Bourlière, Romaric Deydier et al. · The American Journal of Gastroenterology Mar 2006 155
19 Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid‐based cytology in primary cervical cancer screening: The FASE study Joseph Monsonégo, Michael G. Hudgens, Laurent Zerat et al. · International Journal of Cancer Open access 12 Oct 2010 152
20 Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus Philippe Halfon, Marc Bourlière, Guillaume Pénaranda et al. · Comparative Hepatology Open access 11 Jul 2005 152
21 Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: Results of a multicenter, large-scale study Giada Sebastiani, Diego Tempesta, Giovanna Fattovich et al. · Journal of Hepatology 9 Jun 2010 152
22 Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: The GEMHEP GenoCII Study Christopher Payan et al. · Journal of Viral Hepatitis 28 Jun 2005 143
23 Impact of autofluorescence-based identification of parathyroids during total thyroidectomy on postoperative hypocalcemia: a before and after controlled study Fares Benmiloud, Stanislas Rebaudet, Arthur Damien Varoquaux et al. · Surgery 6 Nov 2017 141
24 Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies Marc Bourlière, Guillaume Pénaranda, Christophe Renou et al. · Journal of Viral Hepatitis Open access 3 May 2006 138
25 How to Measure the Diagnostic Accuracy of Noninvasive Liver Fibrosis Indices: The Area Under the ROC Curve Revisited Jérôme Lambert, Philippe Halfon, Guillaume Pénaranda et al. · Clinical Chemistry 7 Jun 2008 137
26 HPV self-sampling or the Pap-smear: A randomized study among cervical screening nonattenders from lower socioeconomic groups in France H Sancho-Garnier, Catherine Tamalet, Philippe Halfon et al. · International Journal of Cancer Open access May 2013 136
27 Prevalence and pathogenicity of binary toxin–positive Clostridium difficile strains that do not produce toxins A and B Catherine Eckert, Aurélie Emirian, Alban Le Monnier et al. · New Microbes and New Infections Open access 4 Dec 2014 135
28 Relapse of hepatitis C virus–associated mixed cryoglobulinemia vasculitis in patients with sustained viral response Dan‐Avi Landau, David Saadoun, Philippe Halfon et al. · Arthritis & Rheumatism 31 Jan 2008 133
29 Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C Philippe Halfon, Yannick Bacq, Anne De Muret et al. · Journal of Hepatology 8 Nov 2006 132
30 Transient opening of trimeric prefusion RSV F proteins Morgan S. A. Gilman, Polina Furmanova-Hollenstein, Gabriel Pascual et al. · Nature Communications Open access 8 May 2019 131
31 Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA Philippe Halfon, Hacène Khiri, V. Gérolami et al. · Journal of Hepatology Sep 1996 131
32 The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases Giada Sebastiani, Laurent Castéra, Philippe Halfon et al. · Alimentary Pharmacology & Therapeutics Open access 9 Oct 2011 124
33 FibroTest-ActiTest as a non-invasive marker of liver fibrosis Philippe Halfon, Mona Munteanu, Thierry Poynard · Gastroentérologie Clinique et Biologique Sep 2008 122
34 GlycoFibroTest Is a Highly Performant Liver Fibrosis Biomarker Derived from DNA Sequencer-based Serum Protein Glycomics Dieter Vanderschaeghe, Wouter Laroy, Erwin Sablon et al. · Molecular & Cellular Proteomics Open access 29 Jan 2009 119
35 Hepatitis B virus genotypes and extrahepatic manifestations P. Cacoub, David Saadoun, Marc Bourlière et al. · Journal of Hepatology 29 Jun 2005 114
36 Persisting Long-Term Benefit of Genotype-Guided Treatment for HIV-Infected Patients Failing Haart. The Viradapt Study: Week 48 Follow-Up Philippe Albert Clevenbergh, Jacques Durant, Philippe Halfon et al. · Antiviral Therapy 2000 114
37 A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease Philippe Halfon, Françoise Imbert‐Bismut, Djamila Messous et al. · Comparative Hepatology Open access 30 Dec 2002 109
38 Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C Paul Calès, Victor de Lédinghen, Philippe Halfon et al. · Liver International Open access 10 Oct 2008 109
39 Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users Marc Bourlière, J. M. Barberin, Michel Rotily et al. · Journal of Viral Hepatitis 2002 106
40 Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis Benjamin Terrier, Fabrice Carrat, Guillaume Géri et al. · Journal of Hepatology 19 Feb 2011 100
41 Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation Thierry Poynard, Philippe Halfon, Laurent Castéra et al. · Alimentary Pharmacology & Therapeutics Open access 22 Jan 2007 99
42 Impact of common risk factors of fibrosis progression in chronic hepatitis C Sina Rüeger et al. · Gut 11 Sep 2014 98
43 A Granulocytic Signature Identifies COVID-19 and Its Severity Joana Vitte, Aïssatou Bailo Diallo, Asma Fatima Boumaza et al. · The Journal of Infectious Diseases Open access 15 Sep 2020 97
44 Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: The fibrovic study – ANRS HC02 P. Cacoub, Fabrice Carrat, Pierre Bédossa et al. · Journal of Hepatology 15 Feb 2008 93
45 Real-Time PCR Assays for Hepatitis C Virus (HCV) RNA Quantitation Are Adequate for Clinical Management of Patients with Chronic HCV Infection Philippe Halfon, Marc Bourlière, Guillaume Pénaranda et al. · Journal of Clinical Microbiology Jul 2006 91
46 Hepatitis C Virus Genotyping Based on 5′ Noncoding Sequence Analysis (Trugene) Philippe Halfon, P. Trimoulet, Marc Bourlière et al. · Journal of Clinical Microbiology Open access May 2001 87
47 The micronucleus assay in human lymphocytes: screening for inter-individual variability and application to biomonitoring Carole Di Giorgio, Michel P. De Méo, Michel Laget et al. · Carcinogenesis 1994 86
48 Safety and feasibility of endoscopic biliary radiofrequency ablation treatment of extrahepatic cholangiocarcinoma Arthur E. Laquière, Christian Boustière, Serge Leblanc et al. · Surgical Endoscopy 10 Jul 2015 81
49 Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: Clinical correlations Alain Lafeuillade, Caroline Solas, Philippe Halfon et al. · HIV Clinical Trials Open access Feb 2002 78
50 HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir Harel Dahari, Laëtitia Canini, Frederik Graw et al. · Journal of Hepatology Open access 21 Feb 2016 74

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.